While the administration’s executive order rapidly expanding access to hallucinogens has energized the industry, clinicians warn that the sample size for a sudden, nationwide dissolution of consciousness remains theoretical.
The executive action, which orders federal health agencies to fast-track psilocybin and MDMA therapies, has prompted a wave of industry optimism. However, biostatisticians at the American Medical Association have flagged severe methodological limitations in the White House’s approach, noting that implementing a nationwide restructuring of the human ego without a double-blind placebo control group introduces massive confounding variables.
"It is crucial to distinguish between a statistically significant breakthrough in psychiatric treatment and a mere correlative spike in self-reported realizations that all matter is a single vibrating cosmic entity," a joint editorial in the New England Journal of Medicine read on Tuesday. The authors added that while the executive order promises widespread access, the causal link between a presidential signature and immediate spiritual enlightenment has not been rigorously peer-reviewed.
While the mandate to rapidly process our collective intergenerational traumas shows promising preliminary markers, we must remember this is an unblinded, open-label rollout.
Furthermore, industry claims that the psychedelics field is "ready to step up" rely heavily on self-reported survey data, which is historically vulnerable to selection bias. Researchers also attached a conflict-of-interest disclosure to the administration's timeline, noting that several startups poised to benefit from the order are currently funded by venture capital firms whose partners frequently self-administer unregulated microdoses in uncontrolled mountainous environments.
Until further randomized, multi-center trials can be conducted to verify the safety profile of a federally induced alternate dimension, experts advise treating the executive order as purely observational. Citizens are recommended to consult with their primary care physician before dissolving their corporeal boundaries, keeping in mind that the current data on astral projection remains strictly anecdotal.